P/E ratio for LHC Group (LHCG)
P/E ratio as of April 2024 (TTM): 82.4
According to LHC Group's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 82.432. At the end of 2021 the company had a P/E ratio of 37.0.
P/E ratio history for LHC Group from 2005 to 2022
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2021 | 37.0 | |
| 2019 | 44.6 | 4% |
| 2018 | 42.9 | 98.07% |
| 2017 | 21.6 | -1.02% |
| 2016 | 21.9 | -10.68% |
| 2015 | 24.5 | -0.29% |
| 2014 | 24.6 | 33.79% |
| 2013 | 18.4 | 31.82% |
| 2012 | 13.9 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Amedisys AMED | 917 | 1,012.19% | 🇺🇸 USA |
 National Healthcare
NHC | 43.9 | -46.72% | 🇺🇸 USA |
 Chemed CHE | 35.0 | -57.58% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.